UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 

 

  FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of

The Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported) February 6 , 2019 (February 3, 2019)

 

 

MJ BIOTECH, INC.

(Exact name of registrant as specified in its charter)

 

 

 

 

 

 

 

 

 

 

 

 

Wyoming

 

000-54616

 

45-2282672

(State or other jurisdiction of

incorporation)

 

(Commission File Number)

 

(IRS Employer

Identification No.)

 

                                               109 East 17 th Street, Suite 80

Cheyenne, Wyoming  82001

(Address of principal executive offices, including zip code)

 

(561) 523-3830

(Registrant ’ s telephone number, including area code)

 

 

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

o  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

o  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

o  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

o  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 


Item 8.01 Other Events.

 

On February 3, 2019, the Company executed a non-binding Letter of Intent to acquire an operating Hemp Extraction CBD operating company. The Letter of Intent was accepted by the current owners of the Hemp Extraction CBD operating company.

 

Closing as proposed in the Letter of Intent is subject to due diligence and regulatory approval.

 

Purchase Price:  $600,000.00

 

Anticipated closing: 90 days or sooner.

 

Purchase Price includes the following:

 

All licenses and permits issued by the State of California for the HEMP Extraction CBD which is currently producing one liter a week of CBD oil. (subject to approval by the regulating authorities of MJB or its nominee). 

 

Item 9.01 Exhibits.

 

99.01  Letter of Intent (redacted)

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

 

 

 

 

 

 

 

 

MJ BIOTECH, INC

 

 

 

 

  Dated February 6, 2019

By:

/s/ Maxine Pierson

 

Maxine Pierson

 

 

Chief Executive   Officer

 

 

 

 

 

 

 

 

 

 

 

 

 


 

Exhibit 99.01

LETTER OF INTENT

 

THIS LETTER OF INTENT (the “Letter”) made as of this 3 rd day of February 2019 (the “Execution Date”),

 

BETWEEN:

 

CBD Extraction Lab (“CBDE”) of________________________________, California

 

and

 

MJ Biotech, Inc of 109 East 17 th Street, Suite 80, Cheyenne, WY (“MJB”)

 

(individually the “Party” and collectively the “Parties”)

 

BACKGROUND:

 

This non-binding Letter of Intent outlines MJBs intent of purchasing the CBD Hemp Extraction operating business referred to as CBDE.

 

Purchase Price: $600,000   USD

 

Term of Escrow:  90 days or sooner.as Agreed to by Both Parties

 

Purchase Price includes the following:

 

All Licenses issued by the City and/ or State of California which is currently for the ________ SQFT of the CBD Hemp Extraction Operating Lab.   

 

1. List of all suppliers that provide any material required to produce the CBD oil 

 

2. List of all buyers of the finished CBD oil extract 

 

3. List (Names, Corporate and personal, Address, Email and telephone numbers of all support companies and/ or individuals that have or are- providing tests of the material supplied and the extracted CBD oil. Also list entities that   provide support to help maintain the equipment in the lab –including- but not limited to – that machinery used to produce the CBD oils.  

 

4. A list of all the equipment that is used to produce the CBD oils (initial list attached). Including Model and Manufacturer numbers/repair records/ warranty data/parts suppliers 

 

5. Training as to how to produce the CBD oil, including ordering product to produce CBD oil, testing of the CBD oil and to the delivery of the CBD oil. 

 

6. Assignment of the Lease, and all Utility records for the production location  

 

Initials MJB_______________ CBDE___________________ 


 

 

Subject to:

 

Evaluation of the Equipment being purchase by an independent third party

 

Written Verification that there is no debt on the business, nor any lawsuits filed, and or threatened, that there are no regulatory actions field and or pending against the Company  

 

NON-BINDING

 

This Letter does not create a binding agreement between the Parties and will not be enforceable. Only the future Escrow agreement, duly executed by the Parties, will be enforceable as defined in such by the terms of the Escrow agreement.

 

 

Read and agree to as of this date

 

Date____ February 4 , __________2019     Date_ February 4,_______________ 2019 

 

 

 

By ____ /s/Maxine Pierson ______________          By ___________________________

 

Maxine Pierson CEO           Title: __________________________ 

of MJ Biotech, Inc.